Preoperative Oral Gabapentine 300 Mg for postoperative analgesia in Lower Limb Orthopedic Surgeries Under Spinal Anesthesia

Single Dose Oral Gabapentine 300 Mg As Preemptive Analgesic For Lower Limb Orthopedic Surgeries Under Spinal Anesthesia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/03/017998

Enrollment

Registered

2019-03-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Drug Tab. Gabapentine 300 mg: Single dose given one hour before Spinal anesthesia. Control Intervention1: Control group Placebo Tab.: Single dose given one hr. before spinal anesthesi

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients receiving spinal anaesthesia for elective lower limb orthopedic surgeries

Exclusion criteria

Exclusion criteria: 1. Patients with allergy to Gabapentin, 2. Patients suffering from epilepsy, liver & renal disease, any chronic pain syndrome, psychiatric illness 3. Patients who have taken NSAID in last 24 hrs were excluded from the study. 4. Patients requiring surgical duration more than 3hrs

Design outcomes

Primary

Measure	Time frame
Total duration of analgesiaTimepoint: Total duration of analgesia	—

Secondary

Measure	Time frame
Total analgesic requirement in 24 hrs.Timepoint: 24 hrs	—

Countries

India

Contacts

Public ContactDr Pradnya S Joshi

Mahatma Gandhi Mission Medical college and hospital

joshispradnya@gmail.com9823752665

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026